BioMed Research International / 2017 / Article / Fig 2

Research Article

Multivalent Fusion DNA Vaccine against Brucella abortus

Figure 2

Lymphoproliferative response. Splenocytes stimulated in vitro with (a) 2 μg/ml or 10 μg/ml of R273S, R278S, or R273-278S recombinant proteins, respectively, and (b) 2 μg/ml or 10 μg/ml of B. abortus 2308 crude Brucella proteins. Results are plotted as mean ± standard deviation. and indicate statistically significant values.
(a)
(b)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.